drugset / Trial / NCT00125684
Bioavailability and Effectiveness of Transdermally Administered Morphine
RandomizedParallel-groupOpen-labelTreatment
Summary
Patients will participate in two arms of the trial, one in which morphine will be administered transdermally, and, after a 3 day wash out period, one in which morphine will be administered subcutaneously.
Timeline
- Start
- 2003-07
- Primary completion
- 2007-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Morphine | Other / unclassified | — | Other |